Literature DB >> 21253162

Introducing a new drug: an objection.

J Lexchin.   

Abstract

Year:  1988        PMID: 21253162      PMCID: PMC2219093     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  10 in total

1.  Introducing a new drug into your practice.

Authors:  W H Palmer; D L Ross
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

2.  Content analysis of drug-detailing by pharmaceutical representatives.

Authors:  E Hemminki
Journal:  Med Educ       Date:  1977-05       Impact factor: 6.251

3.  Differential education concerning therapeutics and resultant physician prescribing patterns.

Authors:  M H Becker; P D Stolley; L Lasagna; J D McEvilla; L M Sloane
Journal:  J Med Educ       Date:  1972-02

4.  Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information.

Authors:  L S Linn; M S Davis
Journal:  Soc Sci Med       Date:  1972-04       Impact factor: 4.634

5.  Aspects of British general practitioners' prescribing.

Authors:  R Mapes
Journal:  Med Care       Date:  1977-05       Impact factor: 2.983

6.  One drug company's sales techniques.

Authors:  P A Murphy
Journal:  N Engl J Med       Date:  1985-07-25       Impact factor: 91.245

7.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

8.  Rational prescribing and sources of information.

Authors:  F Haayer
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634

9.  The relationship between physician characteristics and prescribing appropriateness.

Authors:  P D Stolley; M H Becker; L Lasagna; J D McEvilla; L M Sloane
Journal:  Med Care       Date:  1972 Jan-Feb       Impact factor: 2.983

10.  Physicians' drug innovation and relinquishment.

Authors:  R E Mapes
Journal:  Soc Sci Med       Date:  1977-09       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.